Back to medications
Medication monograph
tisagenlecleucel
Chimeric Antigen Receptor T-cell (CAR-T) TherapyAntineoplasticsImmunotherapy AgentsCD19-directed Chimeric Antigen ReceptorGenetically-modified Autologous T CellsGene Therapy
Clinical reference
Product monograph
KYMRIAH- tisagenlecleucel injection, suspension
Brands & formulations
Family members
Classification
- Chemical class
- Chimeric Antigen Receptor T-cell (CAR-T) Therapy
- Clinical class
- Antineoplastics, Immunotherapy Agents
- Banks class
- CD19-directed Chimeric Antigen Receptor, Genetically-modified Autologous T Cells
- AHFS family
- Gene Therapy